CMS Data Analysis Support for FDA Medical Device Surveillance Under the TEMPO Pr
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring CMS data analysis support for FDA medical device surveillance under the TEMPO program, with estimated solicitation release on November 1, 2026, and estimated award on January 1, 2027. Two contractors will perform CMS data analyses on the CMS-approved platform to directly support medical device surveillance efforts and advance FDA's analytical priorities.
The estimated award value range is $25,000 to $250,000. Interested parties should contact the FDA at cdhracquisitions@fda.hhs.gov.
Forecast text
Two contractors will be utilized to perform CMS data analyses on the CMS-approved platform, directly supporting medical device surveillance efforts and advancing FDA's analytical priorities within the TEMPO program.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast